NEOMYCIN Drug Patent Profile

Which patents cover Neomycin, and when can generic versions of Neomycin launch?

Neomycin is a drug marketed by Pharmafair, Watson Labs, Xgen Pharms, Bausch And Lomb, Padagis Us, Sciegen Pharms Inc, Alcon Pharms Ltd, Ipharm, Nordic Pharma, Amring Pharms, Sandoz, Adrastea Pharma, Bristol Myers Squibb, Chartwell Molecular, Lannett, Lilly, Nostrum Labs Inc, Roxane, Teva, Fougera, and Pharmaderm. and is included in forty-two NDAs.

The generic ingredient in NEOMYCIN is neomycin sulfate; triamcinolone acetonide. There are nineteen drug master file entries for this compound. Additional details are available on the neomycin sulfate; triamcinolone acetonide profile page.

Summary for NEOMYCIN

US Patents:	0
Applicants:	21
NDAs:	42
Drug Prices:	Drug price information for NEOMYCIN
DailyMed Link:	NEOMYCIN at DailyMed

See drug prices for NEOMYCIN

US Patents and Regulatory Information for NEOMYCIN

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pharmaderm	NEOMYCIN SULFATE-TRIAMCINOLONE ACETONIDE	neomycin sulfate; triamcinolone acetonide	OINTMENT;TOPICAL	062607-001	May 23, 1986		DISCN	No	No
Bausch And Lomb	NEOMYCIN SULFATE AND DEXAMETHASONE SODIUM PHOSPHATE	dexamethasone sodium phosphate; neomycin sulfate	SOLUTION/DROPS;OPHTHALMIC	064055-001	Oct 30, 1995		DISCN	No	No
Nostrum Labs Inc	NEOMYCIN SULFATE	neomycin sulfate	TABLET;ORAL	065468-001	Mar 29, 2010		DISCN	No	No
Pharmafair	NEOMYCIN SULFATE AND POLYMYXIN B SULFATE GRAMICIDIN	gramicidin; neomycin sulfate; polymyxin b sulfate	SOLUTION/DROPS;OPHTHALMIC	062383-001	Aug 31, 1982		DISCN	No	No
Roxane	NEOMYCIN SULFATE	neomycin sulfate	TABLET;ORAL	062173-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Pharmafair	NEOMYCIN & POLYMYXIN B SULFATES & BACITRACIN ZINC & HYDROCORTISONE	bacitracin zinc; hydrocortisone; neomycin sulfate; polymyxin b sulfate	OINTMENT;TOPICAL	062381-001	Sep 6, 1985		DISCN	No	No
Sandoz	NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE	hydrocortisone; neomycin sulfate; polymyxin b sulfate	SUSPENSION/DROPS;OPHTHALMIC	062874-001	May 11, 1988		RX	No	Yes

NEOMYCIN Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory for Neomycin Sulphate

Introduction to Neomycin Sulphate

Neomycin sulphate is a broad-spectrum antibiotic used in both human and veterinary medicine. It is crucial for treating various bacterial infections and is a key component in the pharmaceutical and biotech industries.

Global Market Overview

The global neomycin sulphate market is influenced by several factors, including demand from downstream industries, economic conditions, and regional market dynamics.

Regional Market Dynamics

• Asia: The Asian market, particularly China, has experienced fluctuations in neomycin sulphate prices. In the first half of 2023, prices saw a significant incline due to positive demand from pharmaceutical and healthcare industries. However, the second quarter witnessed a decline in prices due to reduced consumption and manufacturing activities. The third quarter of 2023 saw a major slump in prices due to production struggles and supply shortages[1].
• Europe: European markets have seen a consistent uptick in demand driven by the growth of the pharmaceutical industry. Despite some fluctuations due to inflation and currency changes, the overall trend has been positive, with declining inflation rates enhancing consumer purchasing power[1].
• North America: This region is the leading consumer of neomycin sulphate globally. The market has seen strong demand from downstream industries, although economic instability has affected the price trend. The import of neomycin sulphate from Asian countries has also influenced the market dynamics[1][4].

Price Trends and Forecast

Recent Price Trends

• 2023: The first quarter saw a significant rise in prices in Asia and Europe due to increased demand and improved economic conditions. However, the second and third quarters experienced declines, particularly in Asia, due to production issues and supply shortages[1].
• 2024: The price trend is expected to continue its downward trajectory, primarily due to ongoing market volatility and reduced demand. However, there is a forecast for normalization in the coming months as the market adjusts[1][2].

Forecast

• The future price trend of neomycin sulphate is expected to be influenced by demand from downstream industries and regional economic conditions. In Europe, the moderation of inflation and potential lowering of interest rates could spur increased consumer demand, maintaining a positive market outlook[1].
• In North America, the market is expected to be dictated by the demand from downstream industries and the ongoing struggles between the government and pharmaceutical industries[1].

Market Size and Growth

• The global neomycin sulphate market volume was approximately 13 thousand tonnes in 2023 and is anticipated to grow at a CAGR of 3.5% until 2034[4].
• The market is driven by the rising demand for antibiotics and increasing awareness of infectious diseases, contributing to its significant growth[5].

Key Drivers and Challenges

Drivers

• Economic Growth: Economic prosperity, especially in developing countries, has enhanced access and affordability to antibiotics, driving up consumption rates[3].
• Healthcare Infrastructure: Advanced healthcare infrastructure, particularly in the Asia Pacific region, supported by government initiatives, has led to increased demand and development of new antibiotics[3].
• Pharmaceutical Industry Growth: The consistent growth of the pharmaceutical industry in regions like Europe has boosted demand for neomycin sulphate[1].

Challenges

• Production Issues: Production struggles, especially in China, have led to supply shortages and price volatility[1].
• Economic Instability: Economic instability in regions like North America has affected the market dynamics and price trends of neomycin sulphate[1].
• Regulatory and Market Volatility: The uneven trend in trading activities and regulatory challenges have created a deficit in supply, widening the gap between supply and demand[1].

Impact of Global Antibiotics Market

• The global antibiotics market, of which neomycin sulphate is a part, is expected to grow from USD 53.90 billion in 2024 to USD 85.80 billion by 2033, at a CAGR of 5.3%[3].
• The Asia Pacific region dominates the antibiotics market, accounting for over 46% of the global market share in 2023, which significantly influences the demand for neomycin sulphate[3].

Financial Trajectory

• The financial trajectory of neomycin sulphate is closely tied to the overall performance of the pharmaceutical and biotech sectors.
• Investments in research and development, particularly in regions with advanced healthcare infrastructure, are crucial for the growth of the neomycin sulphate market[3].
• The cost of bringing new antibiotics to market, which can exceed $1 billion and take 10-15 years, poses significant financial challenges for pharmaceutical companies[3].

Analyst Insights

• Analysts predict a positive forecast for neomycin sulphate prices in the coming months as the market looks for normalization after a period of volatility[1].
• The market is expected to benefit from the easing of inflationary pressures and potential reductions in interest rates, which could enhance consumer purchasing power and stimulate demand[1].

Key Takeaways

• Regional Influence: The neomycin sulphate market is heavily influenced by regional demand and economic conditions.
• Price Volatility: The market has experienced significant price volatility due to production issues, supply shortages, and economic instability.
• Growth Prospects: Despite challenges, the market is expected to grow at a CAGR of 3.5% until 2034, driven by increasing demand for antibiotics.
• Global Market Context: The neomycin sulphate market is part of the larger antibiotics market, which is expected to reach USD 85.80 billion by 2033.

FAQs

Q1: What are the primary factors influencing the price trend of neomycin sulphate?

• The primary factors include demand from downstream industries, regional economic conditions, production issues, and supply shortages.

Q2: Which region is the leading consumer of neomycin sulphate?

• North America is the leading consumer of neomycin sulphate globally[4].

Q3: What is the expected growth rate of the global neomycin sulphate market?

• The global neomycin sulphate market is anticipated to grow at a CAGR of 3.5% until 2034[4].

Q4: How does the global antibiotics market impact the neomycin sulphate market?

• The global antibiotics market, which is expected to grow significantly, drives up demand for neomycin sulphate, especially in regions like the Asia Pacific[3].

Q5: What are the major challenges faced by the neomycin sulphate market?

• Major challenges include production issues, economic instability, and regulatory and market volatility[1].

Sources

1. Procurement Resource, Neomycin Sulphate Price Trend and Forecast.
2. ChemAnalyst, Global Neomycin Sulphate Prices Face Continued Decline Amid Volatile Market.
3. BioSpace, Antibiotics Market Size to Reach USD 85.80 Billion by 2033.
4. ChemAnalyst, Neomycin Sulphate Market Size, Share, Growth & Forecast.
5. Market Research Intellect, Neomycin Sulfate Market on the Rise Key Drivers and Future Trends.